PT  - JOURNAL ARTICLE
AU  - Ciyou Huang
AU  - Yigang Chen
TI  - Lymphangiogenesis and colorectal cancer
AID  - 10.15537/smj.2017.3.16245
DP  - 2017 Mar 01
TA  - Saudi Medical Journal
PG  - 237--244
VI  - 38
IP  - 3
4099  - http://smj.org.sa/content/38/3/237.short
4100  - http://smj.org.sa/content/38/3/237.full
SO  - Saudi Med J2017 Mar 01; 38
AB  - Lymphatic metastasis is an important event in the progress of metastasis in colorectal cancer (CRC). The purpose of this article is to assess the role of lymphangiogenesis on CRC. In peritumoral areas of CRC, the lymphatic microvessel density (LMVD) is higher than those in normal colorectal tissues. Morever, the high LMVD is correlated with DFS and local recurrence in CRC. The VEGF-C/VEGF-D/VEGFR-3 pathway, sonic hedgehog (Shh) signaling pathway and extracellular matrix (ECM) are involved in the regulation of lymphangiogenesis in CRC. Inhibition of the VEGF-C/VEGF-D/VEGFR-3 pathway by specific antibodies has been reported to efficiently inhibit experimental tumor lymphangiogenesis and metastasis in animal experiments. Although lymphangiogenesis has been reported to play an important role in the occurrence of colon cancer and to be associated with prognosis, it remains unclear whether it is a valid therapeutic target molecule. Further study of the potential of targeting this process for anti-lymphatic therapies is worthwhile.